Acta Pharm Sin B September 2015 PMID 26579469

HIF-1α pathway: role, regulation and intervention for cancer therapy.

Georgina N Masoud, Wei Li

Download social card

Mentions

12
Peak: 1 in Dec 2022
across 4 sources since Dec 2022

Extended reach

553
potential audience

Total likes

4

Video views

456

Mentions per month

Dec 2022 – Oct 2025

Where it's discussed

  • YouTube7 videos
  • News2 articles
  • Blogs2 articles
  • X / Twitter1 posts

AI synopsis

What people are saying

The discussions highlight the critical role of the HIF-1α pathway in cancer biology, with comments emphasizing its potential as a therapeutic target, such as mentions of inhibiting Prolyl Hydroxylases to boost erythropoietin, underscoring the pathway's broad relevance; the tone combines scientific curiosity with optimism about advancing treatments.

AgreementModerate agreement

Most discussions acknowledge the importance of the HIF-1α pathway in cancer progression and potential treatments, indicating general agreement on its significance.

InterestHigh interest

There is a high level of interest reflected by comments on the potential therapeutic implications and the regulation of the pathway, showing engagement with the scientific content.

EngagementModerate engagement

Several posts delve into detailed mechanisms and recent research findings, demonstrating moderate to deep engagement with the topic.

ImpactModerate impact

Participants recognize the research's potential to influence future cancer therapies, though some see it as still emerging and not yet fully applicable.

Abstract in brief

  • The HIF1 pathway plays a key role in cancer progression by helping tumors adapt to low oxygen (hypoxic) conditions, which is common in solid tumors, and its high levels are linked to increased metastasis, poor prognosis, and resistance to therapy.
  • Tumor cells respond to hypoxia by activating survival pathways, especially through the HIF1 pathway, making it an important target for developing new cancer treatments, although targeting it has been challenging.
  • Recent research has advanced our understanding of how HIF1 is regulated and its function in cancer, leading to new therapeutic strategies aimed at inhibiting this pathway to improve cancer treatment outcomes.]

Top posts

Most liked on X and Bluesky
めるん
@merumeru_std · X

・Inhibition of Prolyl Hydroxylases Increases Erythropoietin Production in ESRD ・HIF-1α pathway: role, regulation and intervention for cancer therapy

Oct 24, 2025 · 97 followers View post →

All mentions

めるん
@merumeru_std · X

・Inhibition of Prolyl Hydroxylases Increases Erythropoietin Production in ESRD ・HIF-1α pathway: role, regulation and intervention for cancer therapy

Oct 24, 2025 · 97 followers View post →